Breaking News Instant updates and real-time market news.

GMAB

Genmab

$42.99 /

-0.06 (-0.14%)

, JNJ

Johnson & Johnson

$163.36 /

-0.47 (-0.29%)

10:17
06/22/21
06/22
10:17
06/22/21
10:17

Genmab says Janssen receives European marketing authorizations for DARZALEX

Genmab (GMAB) announced that the European Commission has granted marketing authorization for the daratumumab subcutaneous formulation, known as DARZALEX SC in the European Union, in combination with bortezomib, cyclophosphamide, and dexamethasone for the treatment of adult patients with newly diagnosed systemic light-chain amyloidosis. The EC also approved DARZALEX SC in combination with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received one prior therapy containing a proteasome inhibitor and lenalidomide and were lenalidomide refractory, or who have received at least two prior therapies that included lenalidomide and a PI and have demonstrated disease progression on or after the last therapy. The approvals follow Positive Opinions by the CHMP of the European Medicines Agency in May 2021. In August 2012, Genmab granted Janssen (JNJ) Biotech an exclusive worldwide license to develop, manufacture and commercialize daratumumab.

GMAB

Genmab

$42.99 /

-0.06 (-0.14%)

JNJ

Johnson & Johnson

$163.36 /

-0.47 (-0.29%)

  • 23

    Jun

  • 21

    Jul

GMAB Genmab
$42.99 /

-0.06 (-0.14%)

06/09/21 JPMorgan
Genmab price target raised to DKK 2,700 from DKK 2,500 at JPMorgan
06/07/21 UBS
Genmab price target raised to DKK 2,748 from DKK 2,500 at UBS
05/28/21 Deutsche Bank
Genmab price target raised to DKK 2,850 from DKK 2,750 at Deutsche Bank
05/17/21 JPMorgan
Genmab price target raised to DKK 2,500 from DKK 2,350 at JPMorgan
JNJ Johnson & Johnson
$163.36 /

-0.47 (-0.29%)

06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
06/08/21 Wedbush
Argenx price target lowered to $344 from $356 at Wedbush
06/08/21 Baird
Argenx price target lowered to $333 from $346 at Baird
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved

TODAY'S FREE FLY STORIES

Earnings
Cincinnati Financial reports Q2 adjusted EPS $1.79, consensus 94c » 16:14
07/28/21
07/28
16:14
07/28/21
16:14
CINF

Cincinnati Financial

$113.80 /

-2.28 (-1.96%)

Reports Q2 revenue $2.3B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CINF Cincinnati Financial
$113.80 /

-2.28 (-1.96%)

CINF Cincinnati Financial
$113.80 /

-2.28 (-1.96%)

07/09/21 Piper Sandler
Cincinnati Financial upgraded to Neutral from Underweight at Piper Sandler
05/04/21 Deutsche Bank
Cincinnati Financial price target raised to $110 from $88 at Deutsche Bank
04/14/21 RBC Capital
Cincinnati Financial price target raised to $110 from $105 at RBC Capital
03/12/21 MKM Partners
Cincinnati Financial price target raised to $130 from $110 at MKM Partners
CINF Cincinnati Financial
$113.80 /

-2.28 (-1.96%)

CINF Cincinnati Financial
$113.80 /

-2.28 (-1.96%)

Earnings
ServiceNow sees Q3 subscription revenues $1.4B-$1.405B » 16:14
07/28/21
07/28
16:14
07/28/21
16:14
NOW

ServiceNow

$583.46 /

+0.96 (+0.16%)

Q3 total revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOW ServiceNow
$583.46 /

+0.96 (+0.16%)

NOW ServiceNow
$583.46 /

+0.96 (+0.16%)

07/16/21 Mizuho
ServiceNow price target raised to $640 from $590 at Mizuho
07/09/21 Piper Sandler
ServiceNow price target raised to $585 from $550 at Piper Sandler
06/10/21
Fly Intel: Top five analyst upgrades
06/10/21 Goldman Sachs
ServiceNow upgraded to Conviction Buy from Buy at Goldman Sachs
NOW ServiceNow
$583.46 /

+0.96 (+0.16%)

NOW ServiceNow
$583.46 /

+0.96 (+0.16%)

NOW ServiceNow
$583.46 /

+0.96 (+0.16%)

Earnings
Innoviva reports Q2 EPS 90c vs. 69c last year » 16:14
07/28/21
07/28
16:14
07/28/21
16:14
INVA

Innoviva

$13.67 /

+0.405 (+3.05%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INVA Innoviva
$13.67 /

+0.405 (+3.05%)

Earnings
Tetra Tech sees Q4 EPS 95c-$1.00, consensus $1.00 » 16:14
07/28/21
07/28
16:14
07/28/21
16:14
TTEK

Tetra Tech

$130.87 /

+3.09 (+2.42%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TTEK Tetra Tech
$130.87 /

+3.09 (+2.42%)

TTEK Tetra Tech
$130.87 /

+3.09 (+2.42%)

04/16/21 Maxim
Maxim boosts Tetra Tech target to $160, sees 18% dividend hike
04/12/21 Vertical Research
Tetra Tech initiated with a Hold at Vertical Research
02/01/21 Roth Capital
Tetra Tech price target raised to $135 from $98 at Roth Capital
01/15/21 Maxim
Tetra Tech price target raised to $155 from $140 at Maxim
TTEK Tetra Tech
$130.87 /

+3.09 (+2.42%)

Hot Stocks
PPD not providing financial guidance » 16:14
07/28/21
07/28
16:14
07/28/21
16:14
PPD

PPD

$46.07 /

+0.11 (+0.24%)

Due to the proposed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPD PPD
$46.07 /

+0.11 (+0.24%)

PPD PPD
$46.07 /

+0.11 (+0.24%)

04/28/21 JPMorgan
PPD downgraded to Neutral from Overweight at JPMorgan
04/20/21 Jefferies
PPD downgraded to Hold from Buy at Jefferies
04/19/21
Fly Intel: Top five analyst downgrades
04/19/21 Citi
PPD downgraded to Neutral from Buy at Citi
PPD PPD
$46.07 /

+0.11 (+0.24%)

  • 17
    Sep
PPD PPD
$46.07 /

+0.11 (+0.24%)

PPD PPD
$46.07 /

+0.11 (+0.24%)

Earnings
PPD reports Q2 adjusted EPS 39c, consensus 33c » 16:13
07/28/21
07/28
16:13
07/28/21
16:13
PPD

PPD

$46.07 /

+0.115 (+0.25%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PPD PPD
$46.07 /

+0.115 (+0.25%)

PPD PPD
$46.07 /

+0.115 (+0.25%)

04/28/21 JPMorgan
PPD downgraded to Neutral from Overweight at JPMorgan
04/20/21 Jefferies
PPD downgraded to Hold from Buy at Jefferies
04/19/21
Fly Intel: Top five analyst downgrades
04/19/21 Citi
PPD downgraded to Neutral from Buy at Citi
PPD PPD
$46.07 /

+0.115 (+0.25%)

  • 17
    Sep
PPD PPD
$46.07 /

+0.115 (+0.25%)

PPD PPD
$46.07 /

+0.115 (+0.25%)

Earnings
Landec reports Q4 EPS 7c, consensus (1c) » 16:13
07/28/21
07/28
16:13
07/28/21
16:13
LNDC

Landec

$12.41 /

+0.245 (+2.01%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LNDC Landec
$12.41 /

+0.245 (+2.01%)

LNDC Landec
$12.41 /

+0.245 (+2.01%)

06/02/21
Fly Intel: Top five analyst upgrades
06/02/21 Barrington
Landec upgraded to Outperform from Market Perform at Barrington
04/08/21 Lake Street
Landec price target lowered to $12 from $13 at Lake Street
LNDC Landec
$12.41 /

+0.245 (+2.01%)

LNDC Landec
$12.41 /

+0.245 (+2.01%)

LNDC Landec
$12.41 /

+0.245 (+2.01%)

Earnings
FormFactor sees Q3 EPS 31c-39c, consensus 38c » 16:13
07/28/21
07/28
16:13
07/28/21
16:13
FORM

FormFactor

$36.36 /

+1.56 (+4.48%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FORM FormFactor
$36.36 /

+1.56 (+4.48%)

FORM FormFactor
$36.36 /

+1.56 (+4.48%)

06/25/21 CL King
FormFactor initiated with a Buy at CL King
06/04/21 DA Davidson
DA Davidson upgrades FormFactor to Buy on ramping long-term drivers
06/04/21 DA Davidson
FormFactor upgraded to Buy from Neutral at DA Davidson
04/29/21 Stifel
FormFactor post-earnings reaction 'too harsh,' says Stifel
FORM FormFactor
$36.36 /

+1.56 (+4.48%)

FORM FormFactor
$36.36 /

+1.56 (+4.48%)

Earnings
Echo Global raises FY21 revenue view to $3.45B-$3.55B from $3.15B-$3.35B » 16:13
07/28/21
07/28
16:13
07/28/21
16:13
ECHO

Echo Global

$27.80 /

+0.17 (+0.62%)

Consensus for FY21…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECHO Echo Global
$27.80 /

+0.17 (+0.62%)

06/29/21 Truist
Echo Global price target lowered to $36 from $37 at Truist
01/26/21 Susquehanna
Echo Global downgraded to Neutral from Positive at Susquehanna
01/26/21 Susquehanna
Echo Global downgraded to Neutral from Positive at Susquehanna
01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
ECHO Echo Global
$27.80 /

+0.17 (+0.62%)

ECHO Echo Global
$27.80 /

+0.17 (+0.62%)

Earnings
LSB Industries reports Q2 EPS 42c, consensus 31c » 16:13
07/28/21
07/28
16:13
07/28/21
16:13
LXU

LSB Industries

$8.02 /

-0.205 (-2.49%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LXU LSB Industries
$8.02 /

-0.205 (-2.49%)

LXU LSB Industries
$8.02 /

-0.205 (-2.49%)

Earnings
Meritage Homes reports Q2 EPS $4.36, consensus $3.43 » 16:13
07/28/21
07/28
16:13
07/28/21
16:13
MTH

Meritage Homes

$95.84 /

-0.85 (-0.88%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTH Meritage Homes
$95.84 /

-0.85 (-0.88%)

06/30/21 Goldman Sachs
Meritage Homes price target lowered to $110 from $117 at Goldman Sachs
04/19/21 KeyBanc
Meritage Homes price target raised to $110 from $100 at KeyBanc
04/15/21 Wells Fargo
Meritage Homes initiated with an Equal Weight at Wells Fargo
04/07/21 JPMorgan
JPMorgan lays out long and short homebuilding ideas into earnings
MTH Meritage Homes
$95.84 /

-0.85 (-0.88%)

Earnings
Tetra Tech reports Q3 EPS 95c, consensus 88c » 16:13
07/28/21
07/28
16:13
07/28/21
16:13
TTEK

Tetra Tech

$130.86 /

+3.08 (+2.41%)

Reports Q3 net revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TTEK Tetra Tech
$130.86 /

+3.08 (+2.41%)

TTEK Tetra Tech
$130.86 /

+3.08 (+2.41%)

04/16/21 Maxim
Maxim boosts Tetra Tech target to $160, sees 18% dividend hike
04/12/21 Vertical Research
Tetra Tech initiated with a Hold at Vertical Research
02/01/21 Roth Capital
Tetra Tech price target raised to $135 from $98 at Roth Capital
01/15/21 Maxim
Tetra Tech price target raised to $155 from $140 at Maxim
TTEK Tetra Tech
$130.86 /

+3.08 (+2.41%)

Earnings
ServiceNow reports Q2 adjusted EPS $1.42, consensus $1.21 » 16:13
07/28/21
07/28
16:13
07/28/21
16:13
NOW

ServiceNow

$584.53 /

+2.03 (+0.35%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NOW ServiceNow
$584.53 /

+2.03 (+0.35%)

NOW ServiceNow
$584.53 /

+2.03 (+0.35%)

07/16/21 Mizuho
ServiceNow price target raised to $640 from $590 at Mizuho
07/09/21 Piper Sandler
ServiceNow price target raised to $585 from $550 at Piper Sandler
06/10/21
Fly Intel: Top five analyst upgrades
06/10/21 Goldman Sachs
ServiceNow upgraded to Conviction Buy from Buy at Goldman Sachs
NOW ServiceNow
$584.53 /

+2.03 (+0.35%)

NOW ServiceNow
$584.53 /

+2.03 (+0.35%)

NOW ServiceNow
$584.53 /

+2.03 (+0.35%)

Earnings
Arch Capital reports Q2 after-tax EPS $1.00, consensus 81c » 16:12
07/28/21
07/28
16:12
07/28/21
16:12
ACGL

Arch Capital

$38.08 /

-0.47 (-1.22%)

Gross premiums written by…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACGL Arch Capital
$38.08 /

-0.47 (-1.22%)

ACGL Arch Capital
$38.08 /

-0.47 (-1.22%)

07/09/21 BofA
Progressive added to US 1 List; Arch Capital removed at BofA
04/14/21 RBC Capital
Arch Capital price target raised to $47 from $41 at RBC Capital
03/29/21 Deutsche Bank
Arch Capital price target raised to $46 from $42 at Deutsche Bank
01/19/21 JMP Securities
Arch Capital upgraded to Outperform from Market Perform at JMP Securities
ACGL Arch Capital
$38.08 /

-0.47 (-1.22%)

Earnings
NuVasive sees FY21 adjusted EPS $2.25-$2.35, consensus $2.20 » 16:12
07/28/21
07/28
16:12
07/28/21
16:12
NUVA

NuVasive

$65.43 /

-0.04 (-0.06%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NUVA NuVasive
$65.43 /

-0.04 (-0.06%)

NUVA NuVasive
$65.43 /

-0.04 (-0.06%)

07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
04/05/21 Piper Sandler
FDA appears to approve NuVasive two-level indication, says Piper Sandler
NUVA NuVasive
$65.43 /

-0.04 (-0.06%)

Earnings
NuVasive sees FY21 adjusted EPS $2.25-$2.35, consensus $2.20 » 16:12
07/28/21
07/28
16:12
07/28/21
16:12
NUVA

NuVasive

$65.51 /

+0.04 (+0.06%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NUVA NuVasive
$65.51 /

+0.04 (+0.06%)

NUVA NuVasive
$65.51 /

+0.04 (+0.06%)

07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
04/05/21 Piper Sandler
FDA appears to approve NuVasive two-level indication, says Piper Sandler
NUVA NuVasive
$65.51 /

+0.04 (+0.06%)

Earnings
Echo Global sees Q3 revenue $910M-$940M, consensus $830.19M  16:11
07/28/21
07/28
16:11
07/28/21
16:11
ECHO

Echo Global

$27.84 /

+0.21 (+0.76%)

 
ShowHide Related Items >><<
ECHO Echo Global
$27.84 /

+0.21 (+0.76%)

06/29/21 Truist
Echo Global price target lowered to $36 from $37 at Truist
01/26/21 Susquehanna
Echo Global downgraded to Neutral from Positive at Susquehanna
01/26/21 Susquehanna
Echo Global downgraded to Neutral from Positive at Susquehanna
01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
ECHO Echo Global
$27.84 /

+0.21 (+0.76%)

ECHO Echo Global
$27.84 /

+0.21 (+0.76%)

Earnings
Comfort Systems USA reports Q2 EPS 90c, consensus 91c » 16:11
07/28/21
07/28
16:11
07/28/21
16:11
FIX

Comfort Systems USA

$74.73 /

+0.66 (+0.89%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FIX Comfort Systems USA
$74.73 /

+0.66 (+0.89%)

FIX Comfort Systems USA
$74.73 /

+0.66 (+0.89%)

04/30/21 DA Davidson
Comfort Systems USA price target raised to $75 from $60 at DA Davidson
07/29/20 DA Davidson
Comfort Systems USA price target raised to $45 from $32 at DA Davidson
FIX Comfort Systems USA
$74.73 /

+0.66 (+0.89%)

FIX Comfort Systems USA
$74.73 /

+0.66 (+0.89%)

Hot Stocks
Facebook drops 5% to $356.40 following Q2 results  16:11
07/28/21
07/28
16:11
07/28/21
16:11
FB

Facebook

$373.94 /

+6.14 (+1.67%)

 
ShowHide Related Items >><<
FB Facebook
$373.94 /

+6.14 (+1.67%)

FB Facebook
$373.94 /

+6.14 (+1.67%)

09:35 Today BMO Capital
Alphabet price target raised to $3,000 from $2,700 at BMO Capital
07/26/21 Mizuho
Facebook price target raised to $450 from $400 at Mizuho
07/23/21 Credit Suisse
Facebook price target raised to $480 from $400 at Credit Suisse
07/20/21 Jefferies
Twitter price target raised to $70 from $62 at Jefferies
FB Facebook
$373.94 /

+6.14 (+1.67%)

FB Facebook
$373.94 /

+6.14 (+1.67%)

FB Facebook
$373.94 /

+6.14 (+1.67%)

FB Facebook
$373.94 /

+6.14 (+1.67%)

Earnings
NuVasive reports Q2 adjusted EPS 60c, consensus 44c » 16:11
07/28/21
07/28
16:11
07/28/21
16:11
NUVA

NuVasive

$65.51 /

+0.04 (+0.06%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NUVA NuVasive
$65.51 /

+0.04 (+0.06%)

NUVA NuVasive
$65.51 /

+0.04 (+0.06%)

07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
04/05/21 Piper Sandler
FDA appears to approve NuVasive two-level indication, says Piper Sandler
NUVA NuVasive
$65.51 /

+0.04 (+0.06%)

Hot Stocks
Facebook affirms 2021 expense outlook of $70B-$73B » 16:11
07/28/21
07/28
16:11
07/28/21
16:11
FB

Facebook

$374.08 /

+6.28 (+1.71%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$374.08 /

+6.28 (+1.71%)

FB Facebook
$374.08 /

+6.28 (+1.71%)

09:35 Today BMO Capital
Alphabet price target raised to $3,000 from $2,700 at BMO Capital
07/26/21 Mizuho
Facebook price target raised to $450 from $400 at Mizuho
07/23/21 Credit Suisse
Facebook price target raised to $480 from $400 at Credit Suisse
07/20/21 Jefferies
Twitter price target raised to $70 from $62 at Jefferies
FB Facebook
$374.08 /

+6.28 (+1.71%)

FB Facebook
$374.08 /

+6.28 (+1.71%)

FB Facebook
$374.08 /

+6.28 (+1.71%)

FB Facebook
$374.08 /

+6.28 (+1.71%)

Earnings
FormFactor reports Q2 EPS 36c, consensus 33c » 16:11
07/28/21
07/28
16:11
07/28/21
16:11
FORM

FormFactor

$36.35 /

+1.55 (+4.45%)

Reports Q 2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FORM FormFactor
$36.35 /

+1.55 (+4.45%)

FORM FormFactor
$36.35 /

+1.55 (+4.45%)

06/25/21 CL King
FormFactor initiated with a Buy at CL King
06/04/21 DA Davidson
DA Davidson upgrades FormFactor to Buy on ramping long-term drivers
06/04/21 DA Davidson
FormFactor upgraded to Buy from Neutral at DA Davidson
04/29/21 Stifel
FormFactor post-earnings reaction 'too harsh,' says Stifel
FORM FormFactor
$36.35 /

+1.55 (+4.45%)

FORM FormFactor
$36.35 /

+1.55 (+4.45%)

Earnings
Lam Research sees Q1 EPS $8.02, +/- 50c, consensus $7.77 » 16:10
07/28/21
07/28
16:10
07/28/21
16:10
LRCX

Lam Research

$635.17 /

+12.42 (+1.99%)

Sees Q1 revenue $4.3B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRCX Lam Research
$635.17 /

+12.42 (+1.99%)

LRCX Lam Research
$635.17 /

+12.42 (+1.99%)

05/19/21 Citi
Citi keeps Marvell as top semi equipment pick, Nvidia moves up to two
04/23/21 DA Davidson
Lam Research price target raised to $725 from $615 at DA Davidson
04/22/21 KeyBanc
Lam Research price target raised to $755 from $583 at KeyBanc
04/22/21 Morgan Stanley
Lam Research price target raised to $726 from $568 at Morgan Stanley
LRCX Lam Research
$635.17 /

+12.42 (+1.99%)

LRCX Lam Research
$635.17 /

+12.42 (+1.99%)

LRCX Lam Research
$635.17 /

+12.42 (+1.99%)

LRCX Lam Research
$635.17 /

+12.42 (+1.99%)

Hot Stocks
Facebook expects icreased ad targeting headwinds in 2021 » 16:10
07/28/21
07/28
16:10
07/28/21
16:10
FB

Facebook

$374.00 /

+6.2 (+1.69%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$374.00 /

+6.2 (+1.69%)

FB Facebook
$374.00 /

+6.2 (+1.69%)

09:35 Today BMO Capital
Alphabet price target raised to $3,000 from $2,700 at BMO Capital
07/26/21 Mizuho
Facebook price target raised to $450 from $400 at Mizuho
07/23/21 Credit Suisse
Facebook price target raised to $480 from $400 at Credit Suisse
07/20/21 Jefferies
Twitter price target raised to $70 from $62 at Jefferies
FB Facebook
$374.00 /

+6.2 (+1.69%)

FB Facebook
$374.00 /

+6.2 (+1.69%)

FB Facebook
$374.00 /

+6.2 (+1.69%)

FB Facebook
$374.00 /

+6.2 (+1.69%)

Earnings
Sun Country Airlines reports Q2 adjusted EPS 7c, consensus (16c) » 16:10
07/28/21
07/28
16:10
07/28/21
16:10
SNCY

Sun Country Airlines

$34.75 /

+1.26 (+3.76%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNCY Sun Country Airlines
$34.75 /

+1.26 (+3.76%)

SNCY Sun Country Airlines
$34.75 /

+1.26 (+3.76%)

07/13/21 Susquehanna
Susquehanna expands airline coverage with three initiations
07/13/21 Susquehanna
Sun Country Airlines initiated with a Positive at Susquehanna
05/11/21 Morgan Stanley
Sun Country Airlines price target raised to $39 from $36 at Morgan Stanley
04/26/21 Morgan Stanley
Frontier Group initiated with an Overweight at Morgan Stanley
SNCY Sun Country Airlines
$34.75 /

+1.26 (+3.76%)

  • 20
    May
  • 17
    Mar
SNCY Sun Country Airlines
$34.75 /

+1.26 (+3.76%)

SNCY Sun Country Airlines
$34.75 /

+1.26 (+3.76%)

SNCY Sun Country Airlines
$34.75 /

+1.26 (+3.76%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.